OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
HAYD58

Haydale PLC

Specialty ChemicalsVerified

Haydale's capital structure shows a debt-to-equity ratio of 0.6, indicating a relatively conservative leverage position. However, the company's liquidity is rated as medium, and its free cash flow is negative at -5.115 million GBP, suggesting ongoing cash burn. The current ratio of 2.15 implies the company can cover its short-term liabilities with its current assets, but the negative operating cash flow of -2.963 million GBP raises concerns about its ability to sustain operations without external financing. Profitability metrics are weak, with a return on equity of -1.0767 and a return on assets of -0.5404, both significantly below the industry median for specialty chemicals. The company reported a net loss of 6.11 million GBP and an operating loss of 5.958 million GBP, indicating a challenging operating environment. Gross profit of 2.812 million GBP is insufficient to cover operating expenses, highlighting the need for cost optimization or revenue growth. Haydale's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of diversification increases exposure to sector-specific risks and limits the company's ability to offset losses in one area with gains in another. The company's growth trajectory is uncertain, with no specific revenue growth rates provided in the input data. However, the negative operating and free cash flows suggest a lack of momentum in scaling operations or improving margins. The absence of a clear growth strategy or significant capital expenditure (only -519,000 GBP in capex) further limits visibility into future expansion. Risk factors include liquidity constraints and the potential for dilution, although the latter is currently rated as low. The company's negative net cash position after subtracting total debt is a key flag, indicating a need for additional financing or operational improvements to stabilize its balance sheet. No recent dilutive events are disclosed, but the company's high share count (7.775 billion shares) suggests a history of equity issuance. No recent events such as filings or transcripts are provided in the input data, limiting the ability to assess management's strategic direction or investor sentiment. Analysts have issued a mean price target of 1.00 GBP, with a strong-buy recommendation from one analyst and no buy or hold ratings, suggesting limited consensus on the company's near-term prospects.

30-day price · HAYD(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyHaydale PLC
TickerHAYD.L
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Haydale PLC is a specialty chemicals company that develops and commercializes graphene and graphene-based materials for use in a range of industrial applications, including composites, coatings, and energy storage.

Classification. Haydale is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry, with a confidence level of 0.92 based on verified market data.

Haydale's capital structure shows a debt-to-equity ratio of 0.6, indicating a relatively conservative leverage position. However, the company's liquidity is rated as medium, and its free cash flow is negative at -5.115 million GBP, suggesting ongoing cash burn. The current ratio of 2.15 implies the company can cover its short-term liabilities with its current assets, but the negative operating cash flow of -2.963 million GBP raises concerns about its ability to sustain operations without external financing. Profitability metrics are weak, with a return on equity of -1.0767 and a return on assets of -0.5404, both significantly below the industry median for specialty chemicals. The company reported a net loss of 6.11 million GBP and an operating loss of 5.958 million GBP, indicating a challenging operating environment. Gross profit of 2.812 million GBP is insufficient to cover operating expenses, highlighting the need for cost optimization or revenue growth. Haydale's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of diversification increases exposure to sector-specific risks and limits the company's ability to offset losses in one area with gains in another. The company's growth trajectory is uncertain, with no specific revenue growth rates provided in the input data. However, the negative operating and free cash flows suggest a lack of momentum in scaling operations or improving margins. The absence of a clear growth strategy or significant capital expenditure (only -519,000 GBP in capex) further limits visibility into future expansion. Risk factors include liquidity constraints and the potential for dilution, although the latter is currently rated as low. The company's negative net cash position after subtracting total debt is a key flag, indicating a need for additional financing or operational improvements to stabilize its balance sheet. No recent dilutive events are disclosed, but the company's high share count (7.775 billion shares) suggests a history of equity issuance. No recent events such as filings or transcripts are provided in the input data, limiting the ability to assess management's strategic direction or investor sentiment. Analysts have issued a mean price target of 1.00 GBP, with a strong-buy recommendation from one analyst and no buy or hold ratings, suggesting limited consensus on the company's near-term prospects.
Key takeaways
  • Haydale is a specialty chemicals company with a weak profitability profile and negative cash flows.
  • The company's capital structure is relatively conservative, but liquidity remains a concern.
  • Revenue is concentrated in a single segment, increasing exposure to sector-specific risks.
  • Analysts have issued a strong-buy recommendation, but the lack of consensus and negative financials suggest caution.
  • The company's growth trajectory is unclear, with no significant capital expenditure or revenue growth disclosed.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyGBP
Revenue$4.8M
Gross profit$2.8M
Operating income-$6.0M
Net income-$6.1M
R&D
SG&A
D&A
SBC
Operating cash flow-$3.0M
CapEx-$519.0k
Free cash flow-$5.1M
Total assets$11.3M
Total liabilities$5.6M
Total equity$5.7M
Cash & equivalents
Long-term debt$3.4M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$5.7M
Net cash-$3.4M
Current ratio2.1
Debt/Equity0.6
ROA-54.0%
ROE-1.1%
Cash conversion48.0%
CapEx/Revenue-10.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricHAYDActivity
Op margin-123.6%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-126.8%2.3% medp25 -11.6% · p75 11.8%bottom quartile
Gross margin58.3%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-10.8%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity60.0%59.0% medp25 54.9% · p75 72.9%above median
Observations
IR observations
Mean price target1.00 GBP
Median price target1.00 GBP
High price target1.00 GBP
Low price target1.00 GBP
Mean recommendation1.00 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count0.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate-0.00 GBP
Mean revenue estimate8,000,000 GBP
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 16:26 UTC#cd188176
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 13:57 UTCJob: dfe82291